Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 (CloroCOVID19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04323527
Recruitment Status : Completed
First Posted : March 26, 2020
Last Update Posted : June 21, 2021
Sponsor:
Collaborators:
Marcus Vinícius Guimarães de Lacerda
Mayla Gabriela Silva Borba
Wuelton Marcelo Monteiro
Gisely Cardoso de Melo
Fernando Fonseca de Almeida e Val
Felipe Gomes Naveca
Maria Paula Gomes Mourão
Ludmila Abrahão Hajjar
Jorge Souza Mendonça
Information provided by (Responsible Party):
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado